UNC Medical Center

Chapel Hill, North Carolina 27599

2 studies enrolling now · 7 studies all time

What they study most

Chronic Kidney Disease, Chronic Lymphocytic Leukemia, Diabetic Foot Ulcer, Gastroesophageal Reflux Disease (GERD), Heartburn, Lung Biopsy, Multiple Myeloma, Neurofibromatosis Type 1 (NF1), Non-Erosive Gastro-Esophageal Reflux Disease, Plexiform Neurofibroma

Studies at this site

• Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers — Recruiting now
• A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study — Recruiting now
• MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas — Running, not enrolling
• Financial Difficulty in Patients With Blood Cancer — Completed
• A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD) — Completed
• Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) — Completed
• A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes — Stopped early